Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues

Read full text Summarise with VIRAT
Authors: Niamh M. Higgins, Alan Wells, Nimish Patel, Nicole Muttera, Mattia Trunfio, Alessandra Manca, Amedeo De Nicolò, Micol Ferrara, Stefano Bonora, Jessica Cusato, Alice Palermiti, Antonio D’Avolio
+12 more Marissa Borochoff, Patricia K. Riggs, Elizabeth Hastie, Rabia Samady Atayee, Stephanie Solso, Cheryl Dullano, Vanessa Gomez‐Moreno, Tara L. Tenenbaum, Robert Deiss, Davey M. Smith, Antoine Chaillon, Sara Gianella
Cited by: 0
References: 35

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND AND PURPOSE: Although opioids are central to end of life (EoL) care, tissue-level opioid exposure remains poorly understood. The objective of this study was to characterize the relationship between prescription-derived morphine equivalent daily dose (MEDD) and measured morphine concentrations across multiple organs. EXPERIMENTAL APPROACH: We analysed data from the Last Gift cohort, a community-centred HIV research rapid autopsy programme. Cumulative MEDD for the final 7 and 30 days before death (MEDD-7, MEDD-30) was calculated using prescription data. Postmortem samples from multiple organs were analysed using ultra-high-performance liquid chromatography with tandem mass spectrometry to quantify opioids. Mixed-effects regression models and Pearson correlations evaluated relationships between MEDD and tissue morphine concentrations. KEY RESULTS: Among 261 samples from 27 participants (median age 65 years), 96% had ≥1 detectable opioid. Morphine was most frequently prescribed (78%), followed by fentanyl (41%), hydromorphone (37%), and oxycodone (33%). Median MEDD-7 and MEDD-30 were 940 (IQR 158-3481) and 3430 (IQR 563-9972), respectively. Morphine concentrations were highest in the ascending colon, kidney, duodenum, and liver, and lowest in adipose tissue and cerebrospinal fluid. Tissue morphine concentrations correlated with both MEDD-7 and MEDD-30 (e.g., medulla r = .80; spinal cord r = .77; parietal cortex r = .72; all p < .01). In adjusted mixed-effects models, each 10-fold increase in MEDD-7/-30 predicted a 3.7- to 3.8-fold increase in tissue morphine concentration. CONCLUSION AND IMPLICATIONS: Prescription-based morphine exposure was strongly associated with morphine tissue concentrations across multiple organs, providing a quantitative framework for integrating pharmacologic data into EoL research.

Fields of Study & Subjects

Opioid Use Disorder Treatment Pain Management and Opioid Use Forensic Toxicology and Drug Analysis

Publication details

Journal / source
British Journal of Clinical Pharmacology
Volume
92
Issue
8
Pages
2624–2635
Publication date
30 March 2026
Language
EN